Russell Skibsted

Insider Reports History

Location
15 Tranquility Place, Ladera Ranch, CA
Signature
/s/ Russell Skibsted by John J. Wolfel, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Russell Skibsted:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALIMERA SCIENCES INC Chief Financial Officer & SVP Common Stock 75.5K $292K $3.86 Nov 21, 2023 Direct
Processa Pharmaceuticals, Inc. Chief Financial Officer Restricted Stock Units 108K $5.88K $0.21 Oct 1, 2025 Direct
Processa Pharmaceuticals, Inc. Chief Financial Officer Stock Options (Right to Buy) 324K Oct 1, 2025 Direct
ROCKWELL MEDICAL, INC. EVP, Chief Financial Officer and Chief Business Officer Stock Option (Right to Buy) 80K Sep 9, 2022 Direct
ALIMERA SCIENCES INC Chief Financial Officer & SVP Employee Stock Option (Right to Buy) 50K Nov 21, 2023 Direct

Insider Reports Filed by Russell Skibsted

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCSA Processa Pharmaceuticals, Inc. Oct 1, 2025 2 $0 4 Oct 3, 2025 Chief Financial Officer
PCSA Processa Pharmaceuticals, Inc. Jul 24, 2025 0 $0 4/A Sep 18, 2025 Chief Financial Officer
PCSA Processa Pharmaceuticals, Inc. Jul 16, 2024 1 $0 4 Jul 18, 2024 Chief Financial Officer
PCSA Processa Pharmaceuticals, Inc. Jul 16, 2024 0 $0 3 Jul 18, 2024 Chief Financial Officer
ALIM ALIMERA SCIENCES INC Nov 21, 2023 1 $0 4 Nov 28, 2023 Chief Financial Officer & SVP
ALIM ALIMERA SCIENCES INC Mar 26, 2023 1 $0 4 Mar 28, 2023 Chief Financial Officer & SVP
ALIM ALIMERA SCIENCES INC Jan 9, 2023 2 $0 4 Jan 10, 2023 Chief Financial Officer & SVP
ALIM ALIMERA SCIENCES INC Jan 9, 2023 0 $0 3 Jan 10, 2023 Chief Financial Officer & SVP
RMTI ROCKWELL MEDICAL, INC. Sep 9, 2022 1 $0 4 Sep 13, 2022 EVP, Chief Financial Officer and Chief Business Officer